Evoke Pharma
EVOK
#10165
Rank
HK$0.14 B
Marketcap
HK$85.59
Share price
0.00%
Change (1 day)
117.19%
Change (1 year)

P/S ratio for Evoke Pharma (EVOK)

P/S ratio as of December 2025 (TTM): 1.31

According to Evoke Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.64. At the end of 2025 the company had a P/S ratio of 0.5294.

P/S ratio history for Evoke Pharma from 2013 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20250.5294-24.87%
20240.70463.96%
20230.6778-81.02%
20223.57-67.83%
202111.1-99.62%
2020> 1000
2019N/A
2018N/A
2017N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Ironwood Pharmaceuticals
IRWD
1.58 19.97%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
2.27 73.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amphastar Pharmaceuticals
AMPH
1.71 30.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
3.52 168.18%๐Ÿ‡บ๐Ÿ‡ธ USA